About Olive Capital
As a venture capital firm founded in 2019 which strives allocations in pre-seed to series A stage companies, Olive Funding has carved a distinctive niche. They specialize in delivering entry to allocation prospects into private, early-stage businesses and offer solutions like as venture funding advisory, due diligence, and venture funding funding. They have made 3 allocations so far and their latest allocation was in Meliora Therapeutics in September 2022. They are also featured in Forbes' US 2018 list as 30 under 30 for venture funding.
